HEADER LIGASE 21-JUN-24 9FSJ TITLE CRYSTAL STRUCTURE OF THE HECT DOMAIN OF SMURF 1 IN COMPLEX WITH TITLE 2 INHIBITOR 8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE SMURF1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HSMURF1,HECT-TYPE E3 UBIQUITIN TRANSFERASE SMURF1,SMAD COMPND 5 UBIQUITINATION REGULATORY FACTOR 1,SMAD-SPECIFIC E3 UBIQUITIN-PROTEIN COMPND 6 LIGASE 1; COMPND 7 EC: 2.3.2.26; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMURF1, KIAA1625; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 UBIQUITIN-PROTEIN LIGASE SMURF1, HECT DOMAIN, INHIBITOR, KEYWDS 2 ALLOSTERIC INHIBITION, BMP SIGNALING, PULMONARY VASCULAR REMODELING, KEYWDS 3 LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR N.OSTERMANN REVDAT 2 28-MAY-25 9FSJ 1 JRNL REVDAT 1 16-APR-25 9FSJ 0 JRNL AUTH A.M.K.ROTHMAN,A.FLORENTIN,F.ZINK,C.QUIGLEY,O.BONNEAU, JRNL AUTH 2 R.HEMMIG,A.HACHEY,T.REJTAR,M.THAKER,R.JAIN,S.M.HUANG, JRNL AUTH 3 D.SUTTON,J.ROGER,J.H.ZHANG,S.WEILER,S.COTESTA,J.OTTL, JRNL AUTH 4 S.SRIVASTAVA,A.KORDONSKY,R.AVISHID,E.YARIV,R.RATHI, JRNL AUTH 5 O.KHVALEVSKY,T.TROXLER,S.K.BINMAHFOOZ,O.KLEIFELD, JRNL AUTH 6 N.W.MORRELL,M.HUMBERT,M.J.THOMAS,G.JARAI,R.E.J.BECKWITH, JRNL AUTH 7 J.S.COBB,N.SMITH,N.OSTERMANN,J.TALLARICO,D.SHAW, JRNL AUTH 8 S.GUTH-GUNDEL,G.PRAG,D.J.ROWLANDS JRNL TITL THERAPEUTIC POTENTIAL OF ALLOSTERIC HECT E3 LIGASE JRNL TITL 2 INHIBITION. JRNL REF CELL V. 188 2603 2025 JRNL REFN ISSN 1097-4172 JRNL PMID 40179885 JRNL DOI 10.1016/J.CELL.2025.03.001 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 27310 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1366 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2951 REMARK 3 BIN FREE R VALUE : 0.4564 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 27 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3042 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.45960 REMARK 3 B22 (A**2) : -1.82340 REMARK 3 B33 (A**2) : -1.63620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.300 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.241 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.204 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.226 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.199 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3147 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4256 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1111 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 530 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3147 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 382 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2675 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9FSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUN-24. REMARK 100 THE DEPOSITION ID IS D_1292139637. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27310 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 47.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG1500, 100 MM SPG PH 9, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.68550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.72400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.72350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.72400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.68550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.72350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 438 REMARK 465 ASP A 439 REMARK 465 TYR A 440 REMARK 465 ALA A 561 REMARK 465 PHE A 562 REMARK 465 GLU A 750 REMARK 465 THR A 751 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 433 -73.29 -19.08 REMARK 500 PHE A 555 44.80 -79.25 REMARK 500 ARG A 598 107.32 -32.83 REMARK 500 PRO A 688 169.31 -49.74 REMARK 500 REMARK 500 REMARK: NULL DBREF 9FSJ A 377 751 UNP Q9HCE7 SMUF1_HUMAN 377 751 SEQADV 9FSJ GLY A 375 UNP Q9HCE7 EXPRESSION TAG SEQADV 9FSJ PRO A 376 UNP Q9HCE7 EXPRESSION TAG SEQRES 1 A 377 GLY PRO ASP LEU VAL GLN LYS LEU LYS VAL LEU ARG HIS SEQRES 2 A 377 GLU LEU SER LEU GLN GLN PRO GLN ALA GLY HIS CYS ARG SEQRES 3 A 377 ILE GLU VAL SER ARG GLU GLU ILE PHE GLU GLU SER TYR SEQRES 4 A 377 ARG GLN ILE MET LYS MET ARG PRO LYS ASP LEU LYS LYS SEQRES 5 A 377 ARG LEU MET VAL LYS PHE ARG GLY GLU GLU GLY LEU ASP SEQRES 6 A 377 TYR GLY GLY VAL ALA ARG GLU TRP LEU TYR LEU LEU CYS SEQRES 7 A 377 HIS GLU MET LEU ASN PRO TYR TYR GLY LEU PHE GLN TYR SEQRES 8 A 377 SER THR ASP ASN ILE TYR MET LEU GLN ILE ASN PRO ASP SEQRES 9 A 377 SER SER ILE ASN PRO ASP HIS LEU SER TYR PHE HIS PHE SEQRES 10 A 377 VAL GLY ARG ILE MET GLY LEU ALA VAL PHE HIS GLY HIS SEQRES 11 A 377 TYR ILE ASN GLY GLY PHE THR VAL PRO PHE TYR LYS GLN SEQRES 12 A 377 LEU LEU GLY LYS PRO ILE GLN LEU SER ASP LEU GLU SER SEQRES 13 A 377 VAL ASP PRO GLU LEU HIS LYS SER LEU VAL TRP ILE LEU SEQRES 14 A 377 GLU ASN ASP ILE THR PRO VAL LEU ASP HIS THR PHE CYS SEQRES 15 A 377 VAL GLU HIS ASN ALA PHE GLY ARG ILE LEU GLN HIS GLU SEQRES 16 A 377 LEU LYS PRO ASN GLY ARG ASN VAL PRO VAL THR GLU GLU SEQRES 17 A 377 ASN LYS LYS GLU TYR VAL ARG LEU TYR VAL ASN TRP ARG SEQRES 18 A 377 PHE MET ARG GLY ILE GLU ALA GLN PHE LEU ALA LEU GLN SEQRES 19 A 377 LYS GLY PHE ASN GLU LEU ILE PRO GLN HIS LEU LEU LYS SEQRES 20 A 377 PRO PHE ASP GLN LYS GLU LEU GLU LEU ILE ILE GLY GLY SEQRES 21 A 377 LEU ASP LYS ILE ASP LEU ASN ASP TRP LYS SER ASN THR SEQRES 22 A 377 ARG LEU LYS HIS CYS VAL ALA ASP SER ASN ILE VAL ARG SEQRES 23 A 377 TRP PHE TRP GLN ALA VAL GLU THR PHE ASP GLU GLU ARG SEQRES 24 A 377 ARG ALA ARG LEU LEU GLN PHE VAL THR GLY SER THR ARG SEQRES 25 A 377 VAL PRO LEU GLN GLY PHE LYS ALA LEU GLN GLY SER THR SEQRES 26 A 377 GLY ALA ALA GLY PRO ARG LEU PHE THR ILE HIS LEU ILE SEQRES 27 A 377 ASP ALA ASN THR ASP ASN LEU PRO LYS ALA HIS THR CYS SEQRES 28 A 377 PHE ASN ARG ILE ASP ILE PRO PRO TYR GLU SER TYR GLU SEQRES 29 A 377 LYS LEU TYR GLU LYS LEU LEU THR ALA VAL GLU GLU THR HET TJQ A 801 27 HETNAM TJQ ETHYL 5-[1,3-BENZODIOXOL-5-YLMETHYL(ETHYL)CARBAMOYL]-2, HETNAM 2 TJQ 4-DIMETHYL-1~{H}-PYRROLE-3-CARBOXYLATE FORMUL 2 TJQ C20 H24 N2 O5 FORMUL 3 HOH *247(H2 O) HELIX 1 AA1 GLY A 375 GLN A 392 1 18 HELIX 2 AA2 GLU A 407 LYS A 418 1 12 HELIX 3 AA3 ARG A 420 LYS A 425 1 6 HELIX 4 AA4 GLY A 442 MET A 455 1 14 HELIX 5 AA5 LEU A 456 GLY A 461 5 6 HELIX 6 AA6 ASP A 478 ASN A 482 5 5 HELIX 7 AA7 ASP A 484 HIS A 502 1 19 HELIX 8 AA8 THR A 511 LEU A 519 1 9 HELIX 9 AA9 GLN A 524 GLU A 529 5 6 HELIX 10 AB1 ASP A 532 ASN A 545 1 14 HELIX 11 AB2 ASN A 573 VAL A 577 5 5 HELIX 12 AB3 ASN A 583 ARG A 598 1 16 HELIX 13 AB4 ILE A 600 ILE A 615 1 16 HELIX 14 AB5 PRO A 616 LYS A 621 1 6 HELIX 15 AB6 ASP A 624 ASP A 636 1 13 HELIX 16 AB7 ASP A 639 ASN A 646 1 8 HELIX 17 AB8 SER A 656 PHE A 669 1 14 HELIX 18 AB9 ASP A 670 GLY A 683 1 14 HELIX 19 AC1 GLY A 691 LEU A 695 5 5 HELIX 20 AC2 THR A 724 PHE A 726 5 3 HELIX 21 AC3 SER A 736 GLU A 749 1 14 SHEET 1 AA1 2 HIS A 398 VAL A 403 0 SHEET 2 AA1 2 ARG A 427 PHE A 432 1 O MET A 429 N CYS A 399 SHEET 1 AA2 2 PHE A 463 TYR A 465 0 SHEET 2 AA2 2 LEU A 473 ILE A 475 -1 O GLN A 474 N GLN A 464 SHEET 1 AA3 2 CYS A 556 HIS A 559 0 SHEET 2 AA3 2 LEU A 566 GLU A 569 -1 O LEU A 566 N HIS A 559 SHEET 1 AA4 4 THR A 647 LYS A 650 0 SHEET 2 AA4 4 PHE A 707 LEU A 711 1 O ILE A 709 N LYS A 650 SHEET 3 AA4 4 ARG A 728 ILE A 731 1 O ILE A 729 N HIS A 710 SHEET 4 AA4 4 LYS A 721 HIS A 723 -1 N LYS A 721 O ASP A 730 CRYST1 41.371 91.447 111.448 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024172 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010935 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008973 0.00000 CONECT 3044 3046 3059 3061 CONECT 3045 3046 3060 3062 CONECT 3046 3044 3045 3052 CONECT 3047 3050 3063 CONECT 3048 3066 3068 CONECT 3049 3050 3064 CONECT 3050 3047 3049 3054 CONECT 3051 3054 3065 CONECT 3052 3046 CONECT 3053 3060 CONECT 3054 3050 3051 CONECT 3055 3057 3063 CONECT 3056 3058 3070 CONECT 3057 3055 CONECT 3058 3056 CONECT 3059 3044 3060 CONECT 3060 3045 3053 3059 CONECT 3061 3044 3063 3067 CONECT 3062 3045 3069 3070 CONECT 3063 3047 3055 3061 CONECT 3064 3049 3065 3066 CONECT 3065 3051 3064 3068 CONECT 3066 3048 3064 CONECT 3067 3061 CONECT 3068 3048 3065 CONECT 3069 3062 CONECT 3070 3056 3062 MASTER 246 0 1 21 10 0 0 6 3316 1 27 29 END